Hong Kong University of Science and Technology (HKUST) president Nancy Ip Yuk-yu has been awarded a UN prize for a second time for her "outstanding contributions" in neuroscience, which have enabled the earlier diagnosis and better monitoring of Alzheimer's disease.
Ip was presented with the Unesco-Equatorial Guinea International Prize for Research in the Life Sciences in Paris on Friday.
"Dr Nancy Yuk-yu Ip, president of the Hong Kong University of Science and Technology, is a world-renowned neuroscientist recognised for her outstanding contributions to neuroscience, which have advanced understanding of brain function and Alzheimer's disease" Unesco said.
Ip first received the L'Oreal-Unesco For Women in Science Award in 2004, becoming the first Chinese scientist in the life sciences and the first scientist from Hong Kong to receive the honour. The latest recognition marks her second major accolade from the UN body and makes her the first Hong Kong scientist to have received both prestigious Unesco awards.
Unesco said her research had led to the discovery of new biomarkers, the identification of genetic risk factors and the development of blood tests that enabled earlier diagnosis and better monitoring of Alzheimer’s disease. She has also conducted pioneering research in gene therapy for neurodegenerative diseases.
"Many scientific breakthroughs are the result of cooperation, particularly interdisciplinary cooperation. I believe we should further strengthen cooperation across disciplines, universities and national borders," Xinhua quoted Ip as saying.
"This will play an important role in developing medicines for diseases such as Alzheimer's. We are currently working towards this goal."
Expressing gratitude to her research team and HKUST, Ip said she was honoured to receive the award.
"This recognition belongs not only to me, but also to the many talented and dedicated team members, collaborators and colleagues who have contributed to these achievements," Ip said.
"It reflects our shared commitment to advancing knowledge, deepening our understanding of Alzheimer's disease, and translating scientific discoveries into meaningful benefits for patients and society."
She said Alzheimer's disease was not just a scientific and medical challenge, but also a "deeply human one", profoundly affecting the lives of those living with the condition and their families.
She also stressed the importance of global scientific collaboration and nurturing future generations of scientists.
"As a scientist and university president, I believe we must also empower young researchers by giving them the freedom to pursue their curiosity, the confidence to take intellectual risks, and the support they need to tackle the grand challenges facing humanity," she said.
Ip, 71, became HKUST’s president in 2022, the first woman to lead a public university in Hong Kong.
She holds a PhD in pharmacology from Harvard Medical School and worked in New York before joining HKUST in 1993. She is also head of the Hong Kong Centre for Neurodegenerative Diseases.
Ip is best known for her breakthrough in early detection and genetic analysis of Alzheimer’s disease. In 2021, she led an international research team to develop a highly accurate, non-invasive blood test that measures about 20 proteins to identify the disease.
The blood test offers a cheaper, safer alternative to traditional, expensive invasive brain scans or painful lumbar punctures, boasting an accuracy rate of over 96 per cent for detecting Alzheimer's disease.
She is also a member of the Chinese Academy of Sciences and a Hong Kong deputy to the National People's Congress, China's top legislature.
Under her leadership, HKUST won the bid to establish the city’s third medical school, positioning itself as a unique institution that integrates medical science and engineering to train physician-scientists. The school will receive its first cohort of 50 students in 2028.
The other two laureates are Professor Carlos Martin Montanes of the University of Zaragoza in Spain and Professor Adnane Remmal of Sidi Mohamed Ben Abdellah University of Fez, Morocco. They were honoured for their major contributions to the development of a live attenuated vaccine against tuberculosis and the fight against antimicrobial resistance, respectively.
Ip is the sixth Chinese and the only Hongkonger to receive the prestigious award.
The first Chinese recipient was Professor Tu Youyou, who received the award in 2019 after winning the Nobel Prize for Medicine in 2015, in recognition of her research into parasitic diseases and the discovery of a new antimalarial treatment.
Established in 2008 by Unesco and funded by the Republic of Equatorial Guinea, the Unesco-Equatorial Guinea International Prize for Research in the Life Sciences aims to recognise individuals and institutions that have made outstanding contributions to improving the quality of human life through research in the life sciences, while promoting progress in the field and the achievement of the United Nations Sustainable Development Goals.
HKUST
HKUST President and Chinese Academy of Sciences Academician Prof. Nancy Ip Receives UNESCO Honor for a Second Time
科大校長兼中國科學院院士葉玉如教授再度榮獲聯合國教科文組織獎項
SCMP
Ip honoured for discovering new biomarkers and developing blood tests that enable earlier Alzheimer's diagnosis
Hong Kong University of Science and Technology (HKUST) president Nancy Ip Yuk-yu has been awarded a UN prize for a second time for her "outstanding contributions" in neuroscience, which have enabled the earlier diagnosis and better monitoring of Alzheimer's disease.
Ip was presented with the Unesco-Equatorial Guinea International Prize for Research in the Life Sciences in Paris on Friday.
"Dr Nancy Yuk-yu Ip, president of the Hong Kong University of Science and Technology, is a world-renowned neuroscientist recognised for her outstanding contributions to neuroscience, which have advanced understanding of brain function and Alzheimer's disease" Unesco said.
Ip first received the L'Oreal-Unesco For Women in Science Award in 2004, becoming the first Chinese scientist in the life sciences and the first scientist from Hong Kong to receive the honour. The latest recognition marks her second major accolade from the UN body and makes her the first Hong Kong scientist to have received both prestigious Unesco awards.
Unesco said her research had led to the discovery of new biomarkers, the identification of genetic risk factors and the development of blood tests that enabled earlier diagnosis and better monitoring of Alzheimer’s disease. She has also conducted pioneering research in gene therapy for neurodegenerative diseases.
"Many scientific breakthroughs are the result of cooperation, particularly interdisciplinary cooperation. I believe we should further strengthen cooperation across disciplines, universities and national borders," Xinhua quoted Ip as saying.
"This will play an important role in developing medicines for diseases such as Alzheimer's. We are currently working towards this goal."
Expressing gratitude to her research team and HKUST, Ip said she was honoured to receive the award.
"This recognition belongs not only to me, but also to the many talented and dedicated team members, collaborators and colleagues who have contributed to these achievements," Ip said.
"It reflects our shared commitment to advancing knowledge, deepening our understanding of Alzheimer's disease, and translating scientific discoveries into meaningful benefits for patients and society."
She said Alzheimer's disease was not just a scientific and medical challenge, but also a "deeply human one", profoundly affecting the lives of those living with the condition and their families.
She also stressed the importance of global scientific collaboration and nurturing future generations of scientists.
"As a scientist and university president, I believe we must also empower young researchers by giving them the freedom to pursue their curiosity, the confidence to take intellectual risks, and the support they need to tackle the grand challenges facing humanity," she said.
Ip, 71, became HKUST’s president in 2022, the first woman to lead a public university in Hong Kong.
She holds a PhD in pharmacology from Harvard Medical School and worked in New York before joining HKUST in 1993. She is also head of the Hong Kong Centre for Neurodegenerative Diseases.
Ip is best known for her breakthrough in early detection and genetic analysis of Alzheimer’s disease. In 2021, she led an international research team to develop a highly accurate, non-invasive blood test that measures about 20 proteins to identify the disease.
The blood test offers a cheaper, safer alternative to traditional, expensive invasive brain scans or painful lumbar punctures, boasting an accuracy rate of over 96 per cent for detecting Alzheimer's disease.
She is also a member of the Chinese Academy of Sciences and a Hong Kong deputy to the National People's Congress, China's top legislature.
Under her leadership, HKUST won the bid to establish the city’s third medical school, positioning itself as a unique institution that integrates medical science and engineering to train physician-scientists. The school will receive its first cohort of 50 students in 2028.
The other two laureates are Professor Carlos Martin Montanes of the University of Zaragoza in Spain and Professor Adnane Remmal of Sidi Mohamed Ben Abdellah University of Fez, Morocco. They were honoured for their major contributions to the development of a live attenuated vaccine against tuberculosis and the fight against antimicrobial resistance, respectively.
Ip is the sixth Chinese and the only Hongkonger to receive the prestigious award.
The first Chinese recipient was Professor Tu Youyou, who received the award in 2019 after winning the Nobel Prize for Medicine in 2015, in recognition of her research into parasitic diseases and the discovery of a new antimalarial treatment.
Established in 2008 by Unesco and funded by the Republic of Equatorial Guinea, the Unesco-Equatorial Guinea International Prize for Research in the Life Sciences aims to recognise individuals and institutions that have made outstanding contributions to improving the quality of human life through research in the life sciences, while promoting progress in the field and the achievement of the United Nations Sustainable Development Goals.
Edited by Cannix Yau and Emily Hung